Indaptus Therapeutics, Inc.
INDP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001857044
No open-market purchases or sales by Indaptus Therapeutics, Inc. insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $1.15M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Indaptus Therapeutics, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 0 | 15 | +15 |
| Shares | 0 | 541.7K | +541.7K |
| Value | $0 | $4.24M | +$4.24M |
New holders (15)
Institutions that held Indaptus Therapeutics, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Armistice Capital, LLC | 381,892 | $2.99M | 0.07% |
| Vanguard Group Inc | 75,841 | $594.0K | 0.00% |
| Geode Capital Management, LLC | 27,450 | $214.0K | 0.00% |
| Investment House LLC | 25,653 | $201.0K | 0.01% |
| Citadel Advisors LLC | 14,224 | $111.0K | 0.00% |
| Marshall Wace, LLP | 12,780 | $100.0K | 0.00% |
| Harel Insurance Investments & Financial Services Ltd. | 2,958 | $25.0K | 0.00% |
| Morgan Stanley | 556 | $4.00K | 0.00% |
| UBS Group AG | 132 | $1.00K | 0.00% |
| Wells Fargo & Company | 64 | $0 | 0.00% |
| Group One Trading, L.P. | 13 | $0 | 0.00% |
| Reilly Financial Advisors, LLC | 63 | $0 | 0.00% |
| Cutler Group LP | 32 | $0 | 0.00% |
| Advisor Group Holdings, Inc. | 63 | $0 | 0.00% |
| Steward Partners Investment Advisory, LLC | 28 | $0 | 0.00% |
Sold out (0)
Institutions that held Indaptus Therapeutics, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
None.